CISPLATIN AS 2ND-LINE CHEMOTHERAPY IN THE TREATMENT OF ADVANCED OR RECURRENT LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP

被引：41

作者：

THIGPEN, JT

BLESSING, JA

WILBANKS, GD

机构：

[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,JACKSON,MS 39216

[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216

[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263

[4] RUSH UNIV,RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT OBSTET & GYNECOL,CHICAGO,IL 60612

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1986年 / 9卷 / 01期

关键词：

D O I：

10.1097/00000421-198602000-00005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：18 / 20

页数：3

共 7 条

[1]

GOTTLIEB JA, 1975, CANCER CHEMOTH REP 3, V6, P271

[2]

OMURA GA, 1983, CANCER, V52, P626, DOI 10.1002/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO

[3]

2-E

THIGPEN, JT ;

BLESSING, JA ;

LAGASSE, LD ;

DISAIA, PJ ;

HOMESLEY, HD .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03) :253-256

THIGPEN, JT ;

LAGASSE, L ;

HOMESLEY, H ;

BLESSING, JA .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04) :431-435

[6]

THIGPEN T, 1981, CANCER, V48, P899, DOI 10.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO

[7]

2-6